Abstract
BACKGROUND: The Glu27Glu genotype in the beta-2-adrenergic receptor (ADRB2) is associated with fat mass, body mass index and obesity in females. In our population, we previously found an association of higher body mass index (BMI) among women who reported more physical activity and carried the Glu27 allele as compared to non carriers with the same level of activity.
OBJECTIVE: To examine the lipid metabolism differences, both at rest and during submaximal exercise in ADRB2 Glu27Glu vs Gln27Gln obese women.
SUBJECTS: Eight obese women with the Glu27Glu genotype (age, 43±5 y; body mass index (BMI), 31.7±0.9 kg/m2; percentage fat mass, 42.0±1.3; WHR, 0.83±0.02; and VO2max, 21.6±0.9 ml/kg/min) were compared with seven obese women with the Gln27Gln genotype (age, 43±5 y; BMI, 33.9±1.3 kg/m2; percentage fat mass, 41.6±1.2; WHR, 0.83±0.02; and VO2max, 20.6±0.8 ml/kg/min).
MEASUREMENTS: The ADRB2 polymorphism was identified by PCR-RFLP. Respiratory quotient was determined by indirect calorimetry at baseline, during 1 h of walking on a treadmill and 1 h after the exercise. Plasma triglycerides, glycerol, FFA, hydroxybutyrate, glucose and lactate were assayed by spectrophotometric methods. Insulin, leptin and progesterone were measured by radioimmunoassay. Adrenaline and noradrenaline were quantified by high performance liquid chromatography.
RESULTS: The ADRB2 Glu27Glu subjects had lower plasma glycerol (P=0.047) and lower hydroxybutyrate (P=0.001) throughout the study than the Gln27Gln group. Plasma triglycerides (P=0.001), lactate (P<0.05) and serum insulin (P<0.05) remained higher in the Glu27Glu group vs the Gln27Gln group. The respiratory quotient (RQ) was higher in the Glu27Glu obese women along the study (P=0.046), and fat oxidation was significantly lower in this group during the recovery (P=0.048). The other variables did not differ statistically between groups.
CONCLUSION: These data suggest that both lipolysis and fat oxidation promoted by an acute submaximal exercise intervention could be blunted in the polymorphic ADRB2 Glu27Glu group of our female obese population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Sakane N, Yoshida T, Umekawa T, Kogure A, Kondo M . Beta2-adrenoceptor gene polymorphism and obesity Lancet 1999 353: 1976.
Reynisdottir S, Wahrenberg H, Carlstrom K, Rossner S, Arner P . Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta 2-adrenoceptors Diabetologia 1994 37: 428–435.
Enoksson S, Talbot M, Rife F, Tamborlane WV, Sherwin RS, Caprio S . Impaired in vivo stimulation of lipolysis in adipose tissue by selective beta2-adrenergic agonist in obese adolescent girls Diabetes 2000 49: 2149–2153.
Schiffelers SL, Saris WH, Boomsma F, van Baak MA . beta(1)- and beta(2)-Adrenoceptor-mediated thermogenesis and lipid utilization in obese and lean men J Clin Endocrinol Metab 2001 86: 2191–2199.
Hall IP . Beta 2 adrenoceptor polymorphisms: are they clinically important? Thorax 1996 51: 351–353.
Green SA, Turki J, Innis M, Liggett SB . Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties Biochemistry 1994 33: 9414–9419.
Green SA, Cole G, Jacinto M, Innis M, Liggett SB . A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor J Biol Chem 1993 268: 23116–23121.
McGraw DW, Forbes SL, Kramer LA, Liggett SB . Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression J Clin Invest 1998 102: 1927–1932.
Green SA, Turki J, Hall IP, Liggett SB . Implications of genetic variability of human beta 2-adrenergic receptor structure Pulm Pharmac 1995 8: 1–10.
Lin RCY, Ericsson JO, Benjafield AV, Morris BJ . Association of beta2-adrenoceptor Gln27Glu variant with body weight but not hypertension Am J Hypertens 2001 14: 1201–1204.
Large V, Hellstrom L, Reynisdottir S et al. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function J Clin Invest 1997 100: 3005–3013.
Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P . The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females J Intern Med 1999 245: 253–259.
Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K . Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus Diabetologia 1999 42: 98–101.
Yamada K, Ishiyama-Shigemoto S, Ichikawa F et al. Polymorphism in the 5′-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes J Clin Endocrinol Metab 1999 84: 1754–1757.
Mori Y, Kim-Motoyama H, Ito Y et al. The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men Biochem Biophys Res Commun 1999 258: 138–140.
Meirhaeghe A, Helbecque N, Cottel D, Amouyel P . Beta2-adrenoceptor gene polymorphism, body weight, and physical activity Lancet 1999 353: 896.
Meirhaeghe A, Helbecque N, Cottel D, Amouyel P . Impact of polymorphisms of the human beta2-adrenoceptor gene on obesity in a French population Int J Obes Relat Metab Disord 2000 24: 382–387.
Macho Azcarate T, Marti del Moral A, Martinez Hernandez JA . [Genetic studies of obesity in humans.] Med Clin (Barc) 2000 115: 103–110.
Ehrenborg E, Skogsberg Ruotolo G, Large V, Eriksson P, Arner P, Hamsten A . The Q/E27 polymorphism in the β2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins J Intern Med 2000 247: 651.
Echwald SM, Sorensen TI, Tybjaerg-Hansen A, Andersen T, Pedersen O . Gln27Glu variant of the human beta2-adrenoreceptor gene is not associated with early-onset obesity in Danish men Diabetes 1998 47: 1657–1658.
Kortner B, Wolf A, Wendt D, Beisiegel U, Evans D . Lack of association between a human beta-2 adrenoceptor gene polymorphism (gln27glu) and morbid obesity Int J Obes Relat Metab Disord 1999 23: 1099–1100.
Oberkofler H, Esterbauer H, Hell E, Krempler F, Patsch W . The Gln27Glu polymorphism in the beta2-adrenergic receptor gene is not associated with morbid obesity in Austrian women Int J Obes Relat Metab Disord 2000 24: 388–390.
Meirhaeghe A, Luan J, Selberg-Franks P et al. The effect of the Gly16Arg polymorphism of the beta(2)-adrenergic receptor gene on plasma free fatty acid levels is modulated by physical activity J Clin Endocrinol Metab 2001 86: 5881–5887.
Moore GE, Shuldiner AR, Zmuda JM, Ferrell RE, McCole SD, Hagberg JM . Obesity gene variant and elite endurance performance Metabolism 2001 50: 1391.
Corbalán MS, Marti A, Martínez-González MA, Martínez JA . The 27Glu polymorphism of the β2-adrenergic receptor gene interacts with physical activity on obesity risk among female subjects Clin Genet (in press)
Morris JN, Hardman AE . Walking to health Sports Med 1997 23: 306–332.
Buemann B, Schierning B, Toubro S et al. The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency Int J Obes Relat Metab Disord 2001 25: 467–471.
Ranallo RF, Rhodes EC . Lipid metabolism during exercise Sports Med 1998 26: 29–42.
Galbo H . Exercise Physiology: Humoral function Sports Sci Rev 1992 1: 65.
Wasserman's principles of exercise testing and interpretation 2nd edn Lea & Febiger: Philadelpphia, PA 1994.
WHO. Technical Report Series no. 894 2000 i–xii: 1–253.
Astrup A . Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity Public Health Nutr 2001 4: 499–515.
Tai MM, Castillo TP, Pi-Sunyer FX . Thermic effect of food during each phase of the menstrual cycle Am J Clin Nutr 1997 66: 1110–1115.
Balado D (ed). McArdle, Katch and Katch's exercise physiology 4th edn Williams & Wilkins: Baltimore, Maryland 1996.
Ferrannini E . The theoretical bases of indirect calorimetry: a review Metabolism 1988 37: 287–301.
Marques-Lopes I, Ansorena D, Astiasaran I, Forga L, Martinez JA . Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men Am J Clin Nutr 2001 73: 253–261.
Magalini FI, Marcelletti C, Fegiz G, Del Grande G, Mencuccini A . MEDISYSTEM (R)—a modular computer architecture for integrated management of clinical information and images. Evaluation after one year of use in hospital departments J Clin Comput 1989 17: 89–98.
Boomsma F, Alberts G, van der Hoorn FA, Man in't Veld AJ, Schalekamp MA . Simultaneous determination of free catecholamines and epinine and estimation of total epinine and dopamine in plasma and urine by high-performance liquid chromatography with fluorimetric detection J Chromatogr 1992 574: 109–117.
Ukkola O, Tremblay A, Bouchard C . Beta-2 adrenergic receptor variants are associated with subcutaneous fat accumulation in response to long-term overfeeding Int J Obes Relat Metab Disord 2001 25: 1604–1608.
Ahlborg G, Felig P, Hagenfeldt L, Hendler R, Wahren J . Substrate turnover during prolonged exercise in man. Splachnic and leg metabolism of glucose, free fatty acids, and amino acids J Clin Invest 1974 53: 1080.
McGarry JD, Foster DW . Regulation of hepatic fatty acid oxidation and ketone body production A Rev Biochem J 1980 49: 395.
Iwamoto N, Ogawa Y, Kajihara S et al. Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver Clin Chim Acta 2001 314: 85–91.
Rosmond R, Ukkola O, Chagnon M, Bouchard C, Bjorntorp P . Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men J Intern Med 2000 248: 239–244.
Reaven GM, Lithell H, Landsberg L . Hypertension and associated metabolic abnormalities—the role of insulin resistance and the sympathoadrenal system New Engl J Med 1996 334: 374–381.
Jeppesen J, Hein HO, Suadicani P, Gyntelberg F . High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease Hypertension 2000 36: 226–232.
Ho SC, Chen YM, Woo JL, Leung SS, Lam TH, Janus ED . Association between simple anthropometric indices and cardiovascular risk factors Int J Obes Relat Metab Disord 2001 25: 1689–1697.
Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg AD, Stern MP, Raben N . Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene New Engl J Med 1995 333: 343.
Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC . Association of a polymorphism in the beta 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns New Engl J Med 1995 333: 348.
Corbalan MS, Marti A, Martinez-Gonzalez MA, Forga L, Martinez JA . The influence of a β3-adrenergic polymorphism on the risk of obesity is evident in young adults Int J Obes Relat Metab Disord 2001 25 (Suppl 2): S45.
Arner P . Regulation of lipolysis in fat cells Diabetes Rev 1996 4: 450–463.
Jensen MD . Lipolysis: contribution of regional fat A Rev Nutr 1997 17: 127–139.
Arner P . Catecholamine-induced lipolysis in obesity Int J Obes Relat Metab Disord 1999 23 (Suppl 1): 10–13.
Acknowledgements
We are indebted to Thomas Rau and JL Vizmanos for their valuable counselling in Genetics. Special thanks go to MJ Calasanz and JP Román for their statistical advice. We thank Ana Lorente and Verónica Ciaurriz for the biochemical assays. Gratitude is expressed to Dr J Calabuig and the staff of the University Clinic for their valuable help during the maximal and submaximal trials. Financial support from Línea Especial and Gobierno de Navarra is gratefully recognized. T Macho was supported in part by the Deutsche Akademische Austauschdienst.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Macho-Azcarate, T., Marti, A., González, A. et al. Gln27Glu polymorphism in the beta2 adrenergic receptor gene and lipid metabolism during exercise in obese women. Int J Obes 26, 1434–1441 (2002). https://doi.org/10.1038/sj.ijo.0802129
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802129
Keywords
This article is cited by
-
Environmental Factors and Beta2‐Adrenergic Receptor Polymorphism: Influence on the Energy Expenditure and Nutritional Status of Obese Women
Lipids (2015)
-
Association of ADRB2 polymorphism with triglyceride levels in Tongans
Lipids in Health and Disease (2013)
-
Lifestyle Modifies the Relationship Between Body Composition and Adrenergic Receptor Genetic Polymorphisms, ADRB2, ADRB3 and ADRA2B: A Secondary Analysis of a Randomized Controlled Trial of Physical Activity Among Postmenopausal Women
Behavior Genetics (2010)
-
Association between β-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study
International Journal of Obesity (2005)